104 related articles for article (PubMed ID: 19048219)
1. Non-replicating recombinant vaccinia virus expressing CD80 to enhance T-cell stimulation.
Zajac P
Methods Mol Biol; 2009; 514():151-62. PubMed ID: 19048219
[TBL] [Abstract][Full Text] [Related]
2. Nonreplicating recombinant vaccinia virus encoding human B-7 molecules elicits effective costimulation of naive and memory CD4+ T lymphocytes in vitro.
Marti WR; Zajac P; Spagnoli G; Heberer M; Oertli D
Cell Immunol; 1997 Aug; 179(2):146-52. PubMed ID: 9268498
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of the CD80 costimulatory molecule into ocular melanoma cells using a novel episomal vector.
Uno T; Chen PW; Murray TG; Podack ER; Ksander BR
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2531-9. PubMed ID: 9375572
[TBL] [Abstract][Full Text] [Related]
4. Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
Di Lullo G; Soprana E; Panigada M; Palini A; Erfle V; Staib C; Sutter G; Siccardi AG
J Virol Methods; 2009 Mar; 156(1-2):37-43. PubMed ID: 19038289
[TBL] [Abstract][Full Text] [Related]
5. Dominant host range selection of vaccinia recombinants by rescue of an essential gene.
Holzer GW; Gritschenberger W; Mayrhofer JA; Wieser V; Dorner F; Falkner FG
Virology; 1998 Sep; 249(1):160-6. PubMed ID: 9740787
[TBL] [Abstract][Full Text] [Related]
6. Use of B7 costimulatory molecules as adjuvants in a prime-boost vaccination against Visna/Maedi ovine lentivirus.
de Andrés X; Reina R; Ciriza J; Crespo H; Glaria I; Ramírez H; Grilló MJ; Pérez MM; Andrésdóttir V; Rosati S; Suzan-Monti M; Luján L; Blacklaws BA; Harkiss GD; de Andrés D; Amorena B
Vaccine; 2009 Jul; 27(34):4591-600. PubMed ID: 19538997
[TBL] [Abstract][Full Text] [Related]
7. [Effective method of introducing plasmid DNA into eukaryotic cells by using liposomes for producing vaccinia virus recombinants].
Slepushkin VA; Bukrinskiĭ MI
Biull Eksp Biol Med; 1987 Oct; 104(10):478-80. PubMed ID: 2823928
[TBL] [Abstract][Full Text] [Related]
8. A PCR-based method for manipulation of the vaccinia virus genome that eliminates the need for cloning.
Turner PC; Moyer RW
Biotechniques; 1992 Nov; 13(5):764-71. PubMed ID: 1418979
[TBL] [Abstract][Full Text] [Related]
9. [A novel double expression shuttle vector to get marker-free recombinant modified vaccinia virus Ankara].
Zheng Q; Bi Z; Li M; Hou J; Chen P
Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):926-34. PubMed ID: 22034822
[TBL] [Abstract][Full Text] [Related]
10. Construction and isolation of recombinant vaccinia virus using genetic markers.
Lorenzo MM; Galindo I; Blasco R
Methods Mol Biol; 2004; 269():15-30. PubMed ID: 15114004
[TBL] [Abstract][Full Text] [Related]
11. Transient and inducible expression of vaccinia/T7 recombinant viruses.
Mohamed MR; Niles EG
Methods Mol Biol; 2004; 269():41-50. PubMed ID: 15114006
[TBL] [Abstract][Full Text] [Related]
12. Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells.
Domi A; Moss B
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12415-20. PubMed ID: 12196634
[TBL] [Abstract][Full Text] [Related]
13. Expression of fusion IL2-B7.1(IgV+C) and effects on T lymphocytes.
Kong L; Li Y; Yang Y; Li K
Biochem Cell Biol; 2007 Dec; 85(6):685-95. PubMed ID: 18059527
[TBL] [Abstract][Full Text] [Related]
14. 4-1BBL costimulation retrieves CD28 expression in activated T cells.
Habib-Agahi M; Jaberipour M; Searle PF
Cell Immunol; 2009; 256(1-2):39-46. PubMed ID: 19217084
[TBL] [Abstract][Full Text] [Related]
15. [Mapping of "nonessential" regions in the genome of vaccinia virus].
Loparev VN; Bezdetnova ON; Chernos VI
Mol Gen Mikrobiol Virusol; 1988 Dec; (12):33-8. PubMed ID: 3150771
[TBL] [Abstract][Full Text] [Related]
16. [Construction and biological characteristic for the recombinant modified vaccinia virus ankara co-expressing modified GP5 and M protein of porcine reproductive and respiratory syndrome virus].
Zheng Q; Li P; Cao R; Hou J; Chen P
Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):766-73. PubMed ID: 18724695
[TBL] [Abstract][Full Text] [Related]
17. [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].
Ferrer MF; Zanetti FA; Calamante G
Rev Argent Microbiol; 2007; 39(3):138-42. PubMed ID: 17987847
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus and oncolytic virotherapy of cancer.
Thorne SH; Hwang TH; Kirn DH
Curr Opin Mol Ther; 2005 Aug; 7(4):359-65. PubMed ID: 16121702
[TBL] [Abstract][Full Text] [Related]
19. Engineering recombinant poxviruses using a compact GFP-blasticidin resistance fusion gene for selection.
Wong YC; Lin LC; Melo-Silva CR; Smith SA; Tscharke DC
J Virol Methods; 2011 Jan; 171(1):295-8. PubMed ID: 21073901
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant vaccinia viruses as efficient vectors of biologically active, human B7 costimulation molecules].
Marti WR; Schütz A; Oertli D; Zajac P; Harder F; Heberer M
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):131-6. PubMed ID: 14518227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
